Fish Oil: Drugs vs. Supplements

Sandy Almendarez, VP of Content

April 19, 2013

5 Min Read
Fish Oil: Drugs vs. Supplements

Omega-3 fatty acids are no longer just about fish oil. The development of numerous alternative sources, the improved sustainability and bioavailability of those different forms of omega-3s, plus the competition that arises between supplements and pharmaceuticals make the omega-3 market a challenging one to navigate.

Challenging, yes; but also promising. Omega-3 sales have been steady or climbing in the past few years, and growth is projected for the future. Global omega-3 raw materials revenue in 2011 was US$1.81 billion, according to a Frost & Sullivan market research report commissioned by the Global Organization for EPA and DHA Omega-3s (GOED), an increase of almost 10 percent from 2010, and a 12-percent growth is expected through 2016.

On a global basis, Ellen Schutt, communications director, GOED, said the three largest markets for omega-3s are infant formula, fortified foods and beverages, and nutritional supplements. "In the United States, supplements remain hugely popular," she said, noting the Baby Boomers are the heaviest users.

Baldur Hjaltason, Sales Director, Epax AS, added the traditional omega-3 users, such as those Boomers, may have reached saturation "The challenge will be to educate the younger consumers about the health benefits of omega-3s," he said.

Fortified foods, think functional drinks and nutrition bars, are the way to target the 20- to 40-year-old group, according to Ernesto Hernandez, Ph.D., director of process development, Omega Protein Corp.

Another way to gain more market share is to increase the concentration of eicosapentaenoic acid (EPA) and docosahexaenoic (DHA) a product contains. "GOED is seeing an increase in higher concentrate omega-3 supplement products as consumers learn the importance of higher levels of EPA and DHA and 'trade up' to a product that provides more EPA and DHA per pill," Schutt noted.

Some consumers may go as far as a pharmaceutical for their trade up to a higher omega-3 concentrate. Right now, only three pharmaceuticals are on the market: Omacor/Lovaza worldwide and Epadel in Japan, and all three are indicated for reducing triglycerides. However, many more omega-3 drugs are in the pipeline or on deck; in July 2012, Amarin Corp. received FDA approval for its Vascepa omega-3 drug for high triglycerides, and there are at least 30 other pharmaceuticals or pharmaceutical targets using EPA and/or DHA omega-3s in development.

With pharmaceuticals taking market share, supply may be limited for the increasingly popular higher potency omega-3 supplements, according to Adam Ismail, executive director of GOED. However, he said pharmaceutical omega-3s would not necessarily be a massive strain on raw material supply of lower potency omega-3s.

Still, a poll of INSIDER readers (the majority of respondents were supplement manufacturers/marketers, followed by food/beverage manufacturers/marketers) found 37 percent of respondents agreed that omega-3 pharmaceutical drugs would affect supply. However, 62 percent believe the increasing availability of pharmaceutical-grade EPA/DHA will increase the demand for all fish oil products, including supplements.

"Lovaza/Omacor helped the industry overall by raising awareness and credibility of omega-3s among consumers who are comforted by the fact that a doctor is recommending an omega-3 product," Schutt said. "This will result in an increase of alternative marine sources and new types of omega-3 oils being developed."

Higher potency omega-3 products are also a big market trend. "We are seeing an increased interest in higher omega-3 concentrates from our business-to-business customer base, suggesting that they are formulating products with higher omega-3 levels presumably based on an increased demand for these higher concentrates from their customers," said Steve Dillingham, general manager, GC RIEBER OILS Inc.

Omega-3 drugs, with their high price point and marketing messages, may turn consumers on to the more affordable supplement market. "This is certainly a boon for high omega-3 concentrate supplements readily available without prescription, which are less expensive than typical out-of-pocket costs for the omega-3 prescriptives, typically," Dillingham said.

Wael Massrieh, Ph.D., vice president, scientific affairs, Neptune Technologies & Bioressources Inc., added supplements aren't as restricted in their health claims as pharmaceuticals are, so he said omega-3s still have an edge over drugs. "The indication that Neptune krill oil (NKO®) is taken for is not solely for the reduction of triglycerides," he said. "NKO® has also been shown to increase high-density lipoprotein (HDL) cholesterol and decrease low-density lipoprotein (LDL) cholesterol, which are the two other important criteria in managing in cardiovascular health. Furthermore, NKO not only provides omega-3s, but is taken because of its two other major components, namely, phospholipids and astaxanthin."

Omega-3s from fish or plant sources are becoming more popular even as doctors are writing prescriptions to similar drugs. The supplement business is surviving by offering sustainable, easy-to-take products with health claims that go beyond the heart.

Prescription omega-3s are helping the supplement industry boost its credibility and popularity.

While heart health is the benefit most liked to omega-3s, more research is mounting to their ability to boost the brain and beyond.

Omega-3 ingredients must be sustainable and fresh when they reach the consumer, or product interest will suffer.

Learn more on how industry views omega-3 product development in the SupplySide Omega-3 Insights " State of Marine-Sourced Omega-3s " by Karen Butler.

The SupplySide Omega-3 Insights Defining the Global Market Digital Issue offers:

·         Omega-3 market trends in the article, Omega-3 Market Update: Numbers, Trends and Challenges" by Ellen Schutt,

·         Information on pharmaceutical omega-3 products in the article, "Limited Omega-3 Pharma Market Poised for Growth, Opportunities" by Steve Myers, and

·         Insight into adding omega-3s to functional foods in the article " Nothing 'Fishy' About Omega-3s" by Jeanne Turner.

About the Author

Sandy Almendarez

VP of Content, Informa

Summary

• Well-known subject matter expert within the health & nutrition industry with more than 15 years’ experience reporting on natural products.

• She cares a lot about how healthy products are made, where their ingredients are sourced and how they affect human health.

• She knows that it’s the people behind the businesses — their motivations, feelings and emotions — drive industry growth, so that’s where she looks for content opportunities.

Sandy Almendarez is VP of Content for SupplySide and an award-winning journalist. She oversees the editorial and content marketing teams for the B2B media brands SupplySide Supplement Journal and SupplySide Food & Beverage Journal, the education programming for the health and nutrition trade shows SupplySide Connect New Jersey and SupplySide West, the education program SupplySide Fresh for industry newcomers and community engagement across the SupplySide portfolio. She is a seasoned content strategist with a passion for health, good nutrition, sustainability and inclusion. With over 15 years of experience in the health and nutrition industry, Sandy brings a wealth of knowledge to her role as a content-focused business leader. With specialization in topics ranging from product development to content engagement, creative marketing and c-suite decision making, her work is known for its engaging style and its relevance for business leaders in the health and nutrition industry.

In her free time, Sandy loves running, drinking hot tea and watching her two kids grow up. She brews her own “Sandbucha” homemade kombucha; she’s happy to share if you’re ever in Phoenix!

Awards:

Speaker credentials

Resides in

  • Phoenix, AZ

Education

  • Arizona State University

Contact:

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like